316 related articles for article (PubMed ID: 3555785)
1. Determinants of tissue oestradiol levels in human breast cancer.
Santen RJ
Cancer Surv; 1986; 5(3):597-616. PubMed ID: 3555785
[TBL] [Abstract][Full Text] [Related]
2. Control and expression of oestrone sulphatase activities in human breast cancer.
Pasqualini JR; Chetrite G; Nestour EL
J Endocrinol; 1996 Sep; 150 Suppl():S99-105. PubMed ID: 8943793
[TBL] [Abstract][Full Text] [Related]
3. Human mammary cancer as a site of sex steroid metabolism.
Vermeulen A
Cancer Surv; 1986; 5(3):585-95. PubMed ID: 3555784
[TBL] [Abstract][Full Text] [Related]
4. Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.
Miller WR; Stuart M; Sahmoud T; Dixon JM
Br J Cancer; 2002 Oct; 87(9):950-5. PubMed ID: 12434282
[TBL] [Abstract][Full Text] [Related]
5. The effect of ethynyloestradiol and medroxyprogesterone acetate on the in vivo uptake and metabolism of 3H-oestradiol by breast tumour tissue in postmenopausal women.
Reed MJ; Beranek PA; Bonney RC; Ghilchik MW; James VH
Anticancer Res; 1987; 7(6):1265-9. PubMed ID: 2831795
[TBL] [Abstract][Full Text] [Related]
6. Ethanolic extracts of black cohosh (Actaea racemosa) inhibit growth and oestradiol synthesis from oestrone sulphate in breast cancer cells.
Rice S; Amon A; Whitehead SA
Maturitas; 2007 Apr; 56(4):359-67. PubMed ID: 17125943
[TBL] [Abstract][Full Text] [Related]
7. Oestrone sulphatase activity in normal and malignant breast tissues: relationship with tumour location.
Chapman O; Purohit A; Wang DY; Ghilchik MW; Reed MJ
Anticancer Res; 1995; 15(4):1467-71. PubMed ID: 7654035
[TBL] [Abstract][Full Text] [Related]
8. The regulation and inhibition of 17beta-hydroxysteroid dehydrogenase in breast cancer.
Purohit A; Tutill HJ; Day JM; Chander SK; Lawrence HR; Allan GM; Fischer DS; Vicker N; Newman SP; Potter BV; Reed MJ
Mol Cell Endocrinol; 2006 Mar; 248(1-2):199-203. PubMed ID: 16414180
[TBL] [Abstract][Full Text] [Related]
9. Endogenous oestrogens and androgens in normal and malignant endometrial and mammary tissues.
Thijssen JH; Blankenstein MA
Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1953-9. PubMed ID: 2632276
[TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.
Schindler AE; Bolt HM; Zwirner M; Hochlehnert G; Göser R
Arzneimittelforschung; 1982; 32(7):787-91. PubMed ID: 6289846
[TBL] [Abstract][Full Text] [Related]
11. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
Murphy MJ
Oncologist; 1998; 3(2):129-130. PubMed ID: 10388095
[TBL] [Abstract][Full Text] [Related]
12. The origin of oestrone sulphate in normal and malignant breast tissues in postmenopausal women.
Purohit A; Riaz AA; Ghilchik MW; Reed MJ
Horm Metab Res; 1992 Nov; 24(11):532-6. PubMed ID: 1452119
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
Santen RJ; Leszczynski D; Tilson-Mallet N; Feil PD; Wright C; Manni A; Santner SJ
Ann N Y Acad Sci; 1986; 464():126-37. PubMed ID: 3524346
[TBL] [Abstract][Full Text] [Related]
14. Aromatase inhibitors and other novel agents in breast cancer treatment.
Saji S; Toi M
Expert Opin Emerg Drugs; 2002 Oct; 7(2):303-19. PubMed ID: 15989553
[TBL] [Abstract][Full Text] [Related]
15. Effects of sex steroids on proliferation in normal mammary tissue.
Söderqvist G
Ann Med; 1998 Dec; 30(6):511-24. PubMed ID: 9920352
[TBL] [Abstract][Full Text] [Related]
16. In situ aromatization enhances breast tumor estradiol levels and cellular proliferation.
Yue W; Wang JP; Hamilton CJ; Demers LM; Santen RJ
Cancer Res; 1998 Mar; 58(5):927-32. PubMed ID: 9500452
[TBL] [Abstract][Full Text] [Related]
17. Regulation of aromatase and sulphatase in breast tumour cells.
Purohit A; Wang DY; Ghilchik MW; Reed MJ
J Endocrinol; 1996 Sep; 150 Suppl():S65-71. PubMed ID: 8943789
[TBL] [Abstract][Full Text] [Related]
18. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.
Kaaks R; Rinaldi S; Key TJ; Berrino F; Peeters PH; Biessy C; Dossus L; Lukanova A; Bingham S; Khaw KT; Allen NE; Bueno-de-Mesquita HB; van Gils CH; Grobbee D; Boeing H; Lahmann PH; Nagel G; Chang-Claude J; Clavel-Chapelon F; Fournier A; Thiébaut A; González CA; Quirós JR; Tormo MJ; Ardanaz E; Amiano P; Krogh V; Palli D; Panico S; Tumino R; Vineis P; Trichopoulou A; Kalapothaki V; Trichopoulos D; Ferrari P; Norat T; Saracci R; Riboli E
Endocr Relat Cancer; 2005 Dec; 12(4):1071-82. PubMed ID: 16322344
[TBL] [Abstract][Full Text] [Related]
19. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
20. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.
Zhang Y; Kulp SK; Sugimoto Y; Farrar WB; Brueggemeier RW; Lin YC
Anticancer Res; 1998; 18(4A):2541-6. PubMed ID: 9703907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
